Eton Pharmaceuticals Inc. logo

Eton Pharmaceuticals Inc.

ETON | NASDAQ
Chart Builder DCF Calculator
$55.31
-$0.19 (-0.34%)
At close: Sep 21, 2026, 4:00 PM ET
$56
+$0.69 (+1.25%)
Pre-market: Sep 22, 2026, 8:18 AM ET

Market Data

Market Cap
$1.52B
Enterprise Value
$1.5B
Beta
0.90
Average Volume
517.16K
Shares Outstanding (Diluted)
32.3M
Shares Change YoY
21.92%
Institutional Ownership
65.18%
Exchange
NASDAQ
ISIN
US29772L1089

Price Performance

Price Change 1M
-13.6%
Price Change 3M
65.2%
Price Change 6M
132.0%
Price Change YTD
240.2%
Price Change 1Y
201.1%
Price Change 3Y
1092.0%
Price Change 5Y
1004.0%
1M CAGR (ann.)
24.0%
1Y CAGR (ann.)
199.6%
5Y CAGR (ann.)
61.3%
All-Time CAGR
32.0%

Valuation

PE Ratio
145.55
Forward PE
26.88
PEG Ratio
0.16
Forward PEG
1.28
PS Ratio
14.35
Forward PS
6.90
PB Ratio
32.52
P/FCF Ratio
102.84
P/Adj. FCF Ratio
158.98
P/OCF Ratio
100.56
EV/Sales
14.19
EV/EBIT
573.34
EV/EBITDA
98.04
EV/FCF
101.69
Earnings Yield
0.7%
FCF Yield
1.0%
Adj. FCF Yield
0.6%

Financial Health

Net Cash
$16.94M
Total Debt
$9.91M
Cash & Short-Term Investments
$26.85M
Total Assets
$115.81M
Current Ratio
1.52
Quick Ratio
1.30
Debt / Equity Ratio
0.62
Debt / EBITDA
0.65
Debt / FCF
0.67
OCF / Debt
1.53
Interest Coverage
6.14
Altman Z-Score
13.16
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
57.9%
Operating Profit Margin
15.4%
EBITDA Margin
17.6%
Net Profit Margin
12.0%
FCF Margin
13.9%
Adj. FCF Margin
9.0%
SBC / Revenue
4.9%
SBC Impact (per share)
-35.3%

Returns

Return on Assets
11.0%
Return on Equity
40.1%
Return on Invested Capital
20.4%
Return on Capital Employed
23.1%
Return on Tangible Assets
18.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
53.8%
Revenue CAGR 5Y
48.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
3200.0%
EPS CAGR 5Y
150.0%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
46.6%
FCF CAGR 5Y
130.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
119.0%
Revenue Growth Next 3Y
58.9%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
$0.34
EPS Growth Est (next Q)
-585.7%
Revenue Est (next Q)
$41.98M
Revenue Growth Est (next Q)
86.9%

Fair Value Estimates

Graham Number
$3.80
Graham Upside
-93.1%
Lynch Fair Value
$9.50
Lynch Upside
-82.8%
Price Target
$66.67
Price Target Upside
20.5%

Cash Flow

Operating Cash Flow
$15.14M
Free Cash Flow
$14.73M
Adj. Free Cash Flow
$9.53M
FCF Per Share
$0.53
OCF Per Share
$0.55
OCF/S Ratio
14.3%

Income Statement

Revenue
$105.6M
Gross Profit
$61.1M
Operating Income
$16.31M
EBITDA
$15.28M
Net Income
$12.69M
EPS (Diluted)
$0.38
Revenue / Employee
$2.4M
Profit / Employee
$288.36K
Employees
44

© 2026 bestshares.com. All rights reserved.